Gene · 7094
Papers1,871
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,871
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. | J Exp Clin Cancer Res | 2024 | 38263178 | PubTator, text mining | PubMed |
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling. | J Exp Clin Cancer Res | 2024 | 38254102 | PubTator, text mining | PubMed |
| Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation. | Sci Adv | 2024 | 38241367 | PubTator, text mining | PubMed |
| Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells. | Cells | 2024 | 38201302 | PubTator, text mining | PubMed |
| Microbubble Biointerfacing by Regulation of the Platelet Membrane Surfactant Activity at the Gas-Liquid Interface for Acute Thrombosis Targeting. | Angew Chem Int Ed Engl | 2024 | 38196289 | PubTator, text mining | PubMed |
| Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma. | Biochem Biophys Rep | 2024 | 38188362 | PubTator, text mining | PubMed |
| Early growth response 1 as a podocyte injury marker in human glomerular diseases. | Clin Kidney J | 2024 | 38186896 | PubTator, text mining | PubMed |
| A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38180745 | PubTator, text mining | PubMed |
A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5. | J Alzheimers Dis | 2024 | 38160360 | PubTator, text mining | PubMed |
| A Noninvasive Circulating Signature of Combined Right Ventricular Pressure and Volume Overload in Tetralogy of Fallot/Pulmonary Atresia/Major Aortopulmonary Collateral Arteries. | World J Pediatr Congenit Heart Surg | 2024 | 38128927 | PubTator, text mining | PubMed |
| Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study. | Neural Regen Res | 2024 | 38103252 | PubTator, text mining | PubMed |
| Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR-1247-3p-modulated integrin/FAK axis. | Environ Toxicol | 2024 | 38100242 | PubTator, text mining | PubMed |
| Proteomic-based stratification of intermediate-risk prostate cancer patients. | Life Sci Alliance | 2024 | 38052461 | PubTator, text mining | PubMed |
| Talin mechanotransduction in disease. | Int J Biochem Cell Biol | 2024 | 37914021 | PubTator, text mining | PubMed |
| The exploration of mitochondrial-related features helps to reveal the prognosis and immunotherapy methods of colorectal cancer. | Cancer Rep (Hoboken) | 2024 | 37903487 | PubTator, text mining | PubMed |
| Targeting T-cell integrins in autoimmune and inflammatory diseases. | Clin Exp Immunol | 2024 | 37556361 | PubTator, text mining | PubMed |
| New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report. | Pulmonology | 2024 | 37210341 | PubTator, text mining | PubMed |
| TLN1 synergizes with ITGA5 to ameliorate cardiac microvascular endothelial cell dysfunction. | Folia Morphol (Warsz) | 2024 | 37144848 | PubTator, text mining | PubMed |
| The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. | Biomedicines | 2023 | 38255186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7094/papers?page=9